Abbott reports strong Q1 2025 results, driven by medical devices and nutrition products, despite diagnostics decline, and reaffirms full-year guidance.
Abbott reports strong Q1 2025 results, driven by medical devices and nutrition products, despite diagnostics decline, and reaffirms full-year guidance.